HEPATITIS C VIRUS INHIBITORS

The present disclosure is generally directed to antiviral compounds, and more specifically directed to combinations of compounds which can inhibit the function of the NS5A protein encoded by Hepatitis C virus (HCV), compositions comprising such combinations, and methods for inhibiting the function o...

Full description

Saved in:
Bibliographic Details
Main Authors NGUYEN, Van N, LOPEZ, Omar D, NIMJE, Roshan Yadavrao, RAHAMAN, Hasibur, SAULNIER, Mark G, BELEMA, Makonen, WANG, Alan Xiangdong, XU, Ningning, TU, Yong, MEANWELL, Nicholas A, FRENNESSON, David B, HEWAWASAM, Piyasena, WANG, Gan, GUPTA, Samayamunthula Venkata Satya Arun Kumar
Format Patent
LanguageEnglish
French
Published 09.02.2017
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

Abstract The present disclosure is generally directed to antiviral compounds, and more specifically directed to combinations of compounds which can inhibit the function of the NS5A protein encoded by Hepatitis C virus (HCV), compositions comprising such combinations, and methods for inhibiting the function of the NS5A protein. La présente invention concerne de manière générale des composés antiviraux et, en particulier, des associations de composés pouvant inhiber la fonction de la protéine NS5A codée par le virus de l'hépatite C (VHC), des compositions comprenant de telles associations et des méthodes d'inhibition de la fonction de la protéine NS5A.
AbstractList The present disclosure is generally directed to antiviral compounds, and more specifically directed to combinations of compounds which can inhibit the function of the NS5A protein encoded by Hepatitis C virus (HCV), compositions comprising such combinations, and methods for inhibiting the function of the NS5A protein. La présente invention concerne de manière générale des composés antiviraux et, en particulier, des associations de composés pouvant inhiber la fonction de la protéine NS5A codée par le virus de l'hépatite C (VHC), des compositions comprenant de telles associations et des méthodes d'inhibition de la fonction de la protéine NS5A.
Author RAHAMAN, Hasibur
WANG, Alan Xiangdong
MEANWELL, Nicholas A
WANG, Gan
HEWAWASAM, Piyasena
LOPEZ, Omar D
FRENNESSON, David B
BELEMA, Makonen
NIMJE, Roshan Yadavrao
SAULNIER, Mark G
TU, Yong
XU, Ningning
GUPTA, Samayamunthula Venkata Satya Arun Kumar
NGUYEN, Van N
Author_xml – fullname: NGUYEN, Van N
– fullname: LOPEZ, Omar D
– fullname: NIMJE, Roshan Yadavrao
– fullname: RAHAMAN, Hasibur
– fullname: SAULNIER, Mark G
– fullname: BELEMA, Makonen
– fullname: WANG, Alan Xiangdong
– fullname: XU, Ningning
– fullname: TU, Yong
– fullname: MEANWELL, Nicholas A
– fullname: FRENNESSON, David B
– fullname: HEWAWASAM, Piyasena
– fullname: WANG, Gan
– fullname: GUPTA, Samayamunthula Venkata Satya Arun Kumar
BookMark eNrjYmDJy89L5WSQ8XANcAzxDPEMVnBWCPMMCg1W8PTz8HTyDPEPCuZhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfHh_kYGhuYGRsZmxoaOhsbEqQIA2TEjhQ
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate INHIBITEURS DU VIRUS DE L'HÉPATITE C
ExternalDocumentID WO2017023631A1
GroupedDBID EVB
ID FETCH-epo_espacenet_WO2017023631A13
IEDL.DBID EVB
IngestDate Fri Jul 19 15:18:30 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_WO2017023631A13
Notes Application Number: WO2016US44158
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170209&DB=EPODOC&CC=WO&NR=2017023631A1
ParticipantIDs epo_espacenet_WO2017023631A1
PublicationCentury 2000
PublicationDate 20170209
PublicationDateYYYYMMDD 2017-02-09
PublicationDate_xml – month: 02
  year: 2017
  text: 20170209
  day: 09
PublicationDecade 2010
PublicationYear 2017
RelatedCompanies BRISTOL-MYERS SQUIBB COMPANY
RelatedCompanies_xml – name: BRISTOL-MYERS SQUIBB COMPANY
Score 3.0707085
Snippet The present disclosure is generally directed to antiviral compounds, and more specifically directed to combinations of compounds which can inhibit the function...
SourceID epo
SourceType Open Access Repository
SubjectTerms HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title HEPATITIS C VIRUS INHIBITORS
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170209&DB=EPODOC&locale=&CC=WO&NR=2017023631A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMUyxNAE2hBN1gTGarGtimWiqC6yGUoB9HktL85QUoxQD8C0Rvn5mHqEmXhGmEUwMObC9MOBzQsvBhyMCc1QyML-XgMvrAsQglgt4bWWxflImUCjf3i3E1kUN2js2NAe2fizVXJxsXQP8Xfyd1Zydgf02Nb8gqJyxmbGhI7CvxApsSJuDu21hTqB9KQXIlYqbIANbANC8vBIhBqbUPGEGTmfY3WvCDBy-0ClvIBOa-4pFGGQ8XAMcQzxDPIMVnBXCPINCgxU8_Tw8nTxD_IOCRRmU3VxDnD10gdbEw30VH-6P7CZjMQYWYH8_VYJBIc3MJDHVwjjJOM3Y0iTRzDjJxNI8zcDczNIEdFhQooUkgww-k6TwS0szcIG44IXHljIMLCVFpamywHq1JEkOHBwAbiF2Nw
link.rule.ids 230,309,783,888,25577,76883
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5KFetNq2K1akDJLdi62yR7KNK8yGrzIE1rbyVpEhCkFhvx7ztZUu2pt2UHZl_Mzny78wB46GeMoiGcKHiiS4WyZKCgGsoQ8zCmZdlT1hNVIjxfdaf0ZT6YN-BjGwsj8oT-iOSIKFFLlPdS3Nfr_0csS_hWbh7Td-z6fHbioSXX6LivofXDZMsY2mFgBaZsmojbZD-qaUQl_RFipQM0snUBlmZGFZey3lUqzgkchshvVZ5CI1-1oWVua6-14cirv7yxWUvf5gy6rh2OYh7ziWRKMx5NJxL3XW7wOIgm53Dv2LHpKjjM4m9Vi7dgd07kApqI9_NLkAqVJrlOUlIQRhOVpJRpRU9TGa2SBSV6B7r7OF3tJ99By4298WLM_ddrOK5IwgmZdaFZfn3nN6hjy_RWbM0vIIN5Jw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=HEPATITIS+C+VIRUS+INHIBITORS&rft.inventor=NGUYEN%2C+Van+N&rft.inventor=LOPEZ%2C+Omar+D&rft.inventor=NIMJE%2C+Roshan+Yadavrao&rft.inventor=RAHAMAN%2C+Hasibur&rft.inventor=SAULNIER%2C+Mark+G&rft.inventor=BELEMA%2C+Makonen&rft.inventor=WANG%2C+Alan+Xiangdong&rft.inventor=XU%2C+Ningning&rft.inventor=TU%2C+Yong&rft.inventor=MEANWELL%2C+Nicholas+A&rft.inventor=FRENNESSON%2C+David+B&rft.inventor=HEWAWASAM%2C+Piyasena&rft.inventor=WANG%2C+Gan&rft.inventor=GUPTA%2C+Samayamunthula+Venkata+Satya+Arun+Kumar&rft.date=2017-02-09&rft.externalDBID=A1&rft.externalDocID=WO2017023631A1